HYPERPHAGIA IN PRADER-WILLI SYNDROME
Clinical trials for HYPERPHAGIA IN PRADER-WILLI SYNDROME explained in plain language.
Never miss a new study
Get alerted when new HYPERPHAGIA IN PRADER-WILLI SYNDROME trials appear
Sign up with your email to follow new studies for HYPERPHAGIA IN PRADER-WILLI SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for controlling extreme hunger in Prader-Willi syndrome
Disease control ENROLLING_BY_INVITATIONThis study tests the long-term safety of a nasal spray called carbetocin for people with Prader-Willi syndrome who experience severe, constant hunger. About 160 participants who completed a previous study will receive the spray three times a day. The goal is to see if it remains …
Matched conditions: HYPERPHAGIA IN PRADER-WILLI SYNDROME
Phase: PHASE3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New hope for rare hunger disorder: 12-Month drug trial launches
Disease control TerminatedThis study tests whether a daily medication called ARD-101 can safely reduce the intense, constant hunger (hyperphagia) that people with Prader-Willi syndrome experience. About 90 participants who completed a prior study will take the drug for up to 12 months. Researchers will tr…
Matched conditions: HYPERPHAGIA IN PRADER-WILLI SYNDROME
Phase: PHASE3 • Sponsor: Aardvark Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New nasal spray could tame relentless hunger in rare genetic disorder
Symptom relief OngoingThis study tests a nasal spray called carbetocin to help control the constant, severe hunger (hyperphagia) that people with Prader-Willi syndrome experience. About 170 people aged 5 to 30 will receive either the spray or a placebo for 12 weeks. The main goal is to see if the spra…
Matched conditions: HYPERPHAGIA IN PRADER-WILLI SYNDROME
Phase: PHASE3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Symptom relief
Last updated May 12, 2026 13:43 UTC